Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
283
Frequently Asked Questions
What is Market Cap of Rhythm Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rhythm Pharmaceuticals Inc. market cap is $6.46B.
What is the 52-week high for Rhythm Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rhythm Pharmaceuticals Inc. 52 week high is $106.52 as of October 03, 2025.
What is the 52-week low for Rhythm Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rhythm Pharmaceuticals Inc. 52 week low is $45.91 as of October 03, 2025.
What is Rhythm Pharmaceuticals Inc. stock price today?
Rhythm Pharmaceuticals Inc. stock price today is $99.02.
What was Rhythm Pharmaceuticals Inc. stock price yesterday?
Rhythm Pharmaceuticals Inc. stock price yesterday was $97.23.
What is the PE ratio of Rhythm Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rhythm Pharmaceuticals Inc.’s P/E ratio is -32.21.
What is the Price-to-Book ratio of Rhythm Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rhythm Pharmaceuticals Inc. P/B ratio is -521.8441.
What is the 50-day moving average of Rhythm Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rhythm Pharmaceuticals Inc. 50-day moving average is $96.61.
How many employess does Rhythm Pharmaceuticals Inc. has?